Retrospective sequence analysis of the human PRNP gene from the formaldehyde-fixed paraffin-embedded tissues: report of two cases of Creutzfeldt-Jakob disease
Language English Country United States Media print
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
PubMed
17455801
DOI
10.1007/bf02931629
Knihovny.cz E-resources
- MeSH
- Creutzfeldt-Jakob Syndrome diagnosis MeSH
- Molecular Diagnostic Techniques methods MeSH
- Tissue Fixation methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Open Reading Frames genetics MeSH
- Polymerase Chain Reaction methods MeSH
- Polymorphism, Genetic MeSH
- Prion Proteins MeSH
- Prions genetics MeSH
- Retrospective Studies MeSH
- Sequence Analysis, DNA MeSH
- Aged MeSH
- Amino Acid Substitution genetics MeSH
- Paraffin Embedding MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Prion Proteins MeSH
- Prions MeSH
- PRNP protein, human MeSH Browser
The definitive diagnosis of the CJD (Creutzfeldt-Jakob disease; very rare neurodegenerative disorder) can be established only on the basis of post-mortem examination of the central nervous system tissue. Formaldehyde-fixed paraffin-embedded (FFPE) tissue samples may thus constitute the only material available for molecular pathology analyses. We performed post-mortem analysis of the coding region of the prion-protein gene (PRNP)-sequence variations in two definite CJD cases suggestive of genetic form. Only FFPE tissues were available for molecular analyses. The PRNP gene open reading frame was amplified from the genomic DNA (FFPE isolated) in four overlapping, two round semi-nested PCR products that were directly sequenced. We found known pathogenic sequence variation g.532 G>A (Asp178Asn) in patient 1 but we did not find any pathogenic sequence variation in patient 2 despite her origin from the Slovak Orava region. Based on these results, we were able to discriminate between genetic and sporadic form of CJD in patient 1 and 2, respectively. The established method was found to be efficient for the sequence-variation analysis of the entire PRNP gene coding region using the genomic DNA isolated from the FFPE tissues; it can be employed in other retrospective molecular studies.
See more in PubMed
Am J Hum Genet. 1991 Aug;49(2):320-9 PubMed
Gene. 1992 Mar 1;112(1):29-35 PubMed
J Clin Pathol. 1990 Jun;43(6):499-504 PubMed
Cancer Genet Cytogenet. 1998 Nov;107(1):21-7 PubMed
Am J Hum Genet. 1999 Apr;64(4):1063-70 PubMed
Brain Pathol. 1995 Oct;5(4):459-66 PubMed
PCR Methods Appl. 1991 Aug;1(1):17-24 PubMed
Am J Pathol. 2002 Dec;161(6):1961-71 PubMed
Hum Genet. 2001 Jul;109(1):121-4 PubMed
BMC Clin Pathol. 2004 Feb 12;4(1):1 PubMed
Lancet. 1994 Jul 9;344(8915):130-1 PubMed
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2216-20 PubMed
J Neurol. 2002 Nov;249(11):1567-82 PubMed
Nucleic Acids Res. 1999 Aug 15;27(16):e12 PubMed
PCR Methods Appl. 1993 May;2(4):288-92 PubMed
Lancet. 1999 May 15;353(9165):1673-4 PubMed
Hum Mutat. 2000;15(1):7-12 PubMed
Neuropathol Appl Neurobiol. 1997 Feb;23(1):26-35 PubMed
Histol Histopathol. 1997 Jul;12(3):595-601 PubMed
Acta Neuropathol. 1995;89(1):96-8 PubMed
Am J Hum Genet. 2001 Dec;69(6):1225-35 PubMed
Am J Pathol. 1999 Nov;155(5):1467-71 PubMed
Am J Pathol. 1994 Dec;145(6):1301-8 PubMed
Hum Mutat. 2003 Jul;22(1):104-5 PubMed
Nucleic Acids Res. 1989 Mar 25;17(6):2197-201 PubMed
J Biol Chem. 1990 Mar 15;265(8):4718-21 PubMed
Brain. 2003 Jun;126(Pt 6):1333-46 PubMed